Clinical trial · Interventional
Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| ORL Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patient with T3-T4 ORL cancer, relevant to surgery and/or radiotherapy and/or chemotherapy.
- interventionNames
- Other: Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
Primary outcomes (1)
- measure
- The rate of patients for whom tele-therapy will be considered successful.
- timeFrame
- 12 months for each patient
Secondary outcomes (1)
- measure
- The rate of patients with full or partial resolution of speech-language pathology at the end of the telecare consultation.
- timeFrame
- 12 months for each patient
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age ≥ 18 years at study entry. 2. Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy. 3. Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). 4. Patient affiliated to a Social Security system in France. 5. Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedure. Exclusion Criteria: 1. Pregnant or lactating women. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
References
Publications (0)
Data not yet available